Genetic Signatures | GSS - Operating Profit

Stock Price
0.12
Daily Change
-0.03 -17.86%
Monthly
36.90%
Yearly
-71.60%
Q2 Forecast
0.14

Genetic Signatures reported AUD-6.34M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025